ChemoCentryx CCXI
$ 51.99
0.0%
Quarterly report 2022-Q2
added 08-08-2022
ChemoCentryx Financial Statements 2011-2024 | CCXI
Annual Financial Statements ChemoCentryx
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.82 M | 3.74 B | 2.33 B | 616 M | 466 M | 332 M | 163 M | 356 M | 264 M | 399 M | - |
Shares |
69.9 K | 65.7 M | 56.9 M | 49.8 M | 48.4 M | 46.4 M | 43.9 M | 43.3 M | 40.9 M | 35.4 M | - |
Historical Prices |
26.9 | 57 | 42.4 | 12.2 | 9.35 | 7.27 | 3.72 | 8.22 | 6.21 | 11.6 | - |
Net Income |
-132 M | -55.4 M | -55.5 M | -38 M | 17.9 M | -40 M | -47.3 M | -46.9 M | -38.7 M | -39.9 M | -4.62 M |
Revenue |
32.2 M | 64.9 M | 36 M | 42.9 M | 82.5 M | 11.4 M | - | - | 6.06 M | 5.42 M | 31.7 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 64.9 M | - | - | - | - | - | - | - | - | 31.7 M |
Operating Income |
-130 M | -55.2 M | -58.3 M | -40.3 M | 16.5 M | -40.7 M | -47.7 M | -47.4 M | -39.1 M | -39.6 M | -4.3 M |
Interest Expense |
2.7 M | 2.64 M | 2.15 M | 1.22 M | 4 K | - | - | 24 K | 59 K | 794 K | 734 K |
EBITDA |
-127 M | -54.4 M | -56.7 M | -39.8 M | 16.9 M | -40.4 M | -47.2 M | -46.9 M | -38.5 M | -39 M | -3.55 M |
Operating Expenses |
- | 120 M | 94.3 M | 83.1 M | 66 M | 52.2 M | 47.7 M | 47.4 M | 45.2 M | 45 M | 36 M |
General and Administrative Expenses |
78.9 M | 42.2 M | 24.2 M | 20.4 M | 16.5 M | 14.7 M | 14.5 M | 13.6 M | 11.6 M | 10.5 M | 7.62 M |
All numbers in USD currency
Quarterly Income Statement ChemoCentryx
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | 71.2 K | 70.8 K | 70.4 M | 69.9 M | 69.8 K | 69.6 K | 69.5 M | 68.9 M | 63.3 M | 61.3 M | 60.2 M | 58.2 M | 58.1 M | 52.4 K | 50.7 M | 50.3 K | 49.5 K | 48.9 K | 48.8 M | 48.6 M | 48.2 M | 48.1 M | 48.1 M | 47.8 K | 45.8 K | 44.3 K | 44.2 M | 44.1 K | 43.8 K | 43.5 K | 43.4 M | 43.3 M | 43.3 M | 43.1 M | 42.9 M | 42.8 M | 41.3 M | 36.6 M | 36.4 M | 36.2 M | 36.2 M | 32.9 M | 4.39 M | 4.2 M | 4.15 M | 4.39 M |
Net Income |
- | - | -31.7 M | -38.6 M | -40.5 M | -22.3 M | -39.2 M | -29.7 M | -29.9 M | -24.1 M | 20.3 M | -21.7 M | -15.5 M | -12.9 M | -15.2 M | -11.9 M | -10.8 M | -10.9 M | -6.87 M | -9.42 M | 39.7 M | -6.56 M | -9.24 M | -6 M | -7.66 M | -7.07 M | -9.98 M | -15.2 M | -11.6 M | -11.6 M | -12.1 M | -12 M | -12.2 M | -10.9 M | -12.3 M | -11.5 M | -9.54 M | -9.43 M | -9.5 M | -10.2 M | -9.8 M | -10.1 M | -10.9 M | -9.08 M | 18.2 M | -8.66 M | -7.9 M | -6.23 M |
Revenue |
- | - | 11.8 M | 5.46 M | 2.32 M | 17.7 M | 1.81 M | 10.4 M | 4.36 M | 5.08 M | 49.4 M | 6.01 M | 10 M | 10.6 M | 7.17 M | 8.33 M | 9.33 M | 8.98 M | 15 M | 9.55 M | 56.3 M | 9.03 M | 8.94 M | 8.23 M | 4.89 M | 4.25 M | 2.8 M | - | - | - | - | - | - | - | - | - | 725 K | 1.52 M | 1.89 M | 1.93 M | 2.14 M | 1.13 M | 1.13 M | 1.02 M | 26.1 M | 1.44 M | 1.23 M | 2.95 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | -31.6 M | -38.2 M | - | -21.8 M | -38.7 M | -29.3 M | - | -23.9 M | 20.4 M | -22.1 M | - | -13.6 M | -16 M | -12.5 M | - | -11.5 M | -7.48 M | -9.86 M | - | -6.91 M | -9.58 M | -6.31 M | - | -7.33 M | -10.1 M | -15.3 M | - | -11.7 M | -12.2 M | -12.1 M | - | -11.1 M | -12.4 M | -11.7 M | - | -9.55 M | -9.6 M | -10.3 M | - | -10.2 M | -11 M | -8.45 M | - | -8.65 M | -7.98 M | -6.38 M |
Interest Expense |
- | - | 586 K | 597 K | - | 668 K | 695 K | 689 K | - | 700 K | 695 K | 548 K | - | 542 K | 547 K | 542 K | - | 423 K | 181 K | 174 K | - | - | - | - | - | - | - | - | - | - | - | - | - | 4 K | 6 K | 11 K | - | 14 K | 15 K | 17 K | - | 20 K | 21 K | 735 K | - | 117 K | 26 K | 27 K |
EBITDA |
- | - | -29.5 M | -37.2 M | - | -21.8 M | -37.6 M | -29.2 M | - | -23.5 M | 20.7 M | -22 M | - | -13.2 M | -15.7 M | -12.4 M | - | -11.2 M | -7.26 M | -9.74 M | - | -6.6 M | -9.37 M | -6.22 M | - | -7.07 M | -9.97 M | -15.2 M | - | -11.4 M | -11.9 M | -12 M | - | -10.6 M | -12.1 M | -11.5 M | - | -9.13 M | -9.32 M | -10.2 M | - | -9.78 M | -10.7 M | -8.29 M | - | -8.08 M | -7.6 M | -6.19 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | 28.2 M | 26 M | - | 19.6 M | 19.7 M | 16.3 M | - | 10.4 M | 10.3 M | 8.82 M | - | 6.12 M | 5.57 M | 5.5 M | - | 5.37 M | 4.75 M | 4.66 M | - | 3.62 M | 4.18 M | 4.57 M | - | 3.19 M | 3.88 M | 4.08 M | - | 3.81 M | 3.58 M | 3.69 M | - | 3.51 M | 3.38 M | 3.52 M | - | 2.88 M | 2.81 M | 2.96 M | - | 2.62 M | 2.47 M | 2.56 M | - | 1.77 M | 1.94 M | 2.01 M |
All numbers in USD currency